About Us

CLSA Board of Directors



Wade Ackerman

Wade Ackerman

Partner, Covington & Burling LLP

William Annett

Chief Executive Officer OncoCyte

David Beier, J.D.

Managing Director, Bay City Capital


Victoria H. Blatter

Senior Vice President, U.S. Government Affairs, Amgen


Michael Boyd

Senior Vice President, Government Affairs and Policy, Gilead Sciences

Fritz Bittenbender

Senior Vice President, Access & External Affairs, Genentech

Josh Brown

Josh Brown

National Vice President, State Government Relations, Pfizer

David H. Crean

Managing Partner, Cardiff Advisory, LLC


Stephanie Dyson

Vice President of Public Policy and Government Affairs, Biogen


Kyle W. Gano, Ph.D.

Chief Business Development and Strategy Officer, Neurocrine Biosciences, Inc.


Julie Gilmore, Ph.D.

Site Head and Chief Operating Officer, Lilly Gateway Labs

Mark Ginestro

Principal, Healthcare and Life Sciences, KPMG

bryan giraudo

Bryan Giraudo

Chief Financial Officer, Gossamer Bio


Elizabeth Grammer, Esq.

Executive Vice President, General Counsel and Head of Human Resources, Ardelyx, Inc.


Niquette Hunt

CEO, Co-Founder and Board Chair of Candesant Biomedical

jennifer johnson

Jennifer A. Johnson, Ph.D.

Associate General Counsel, DuPont Nutrition & Biosciences

Jeff Jonker

President and CEO, Ambys Medicines


Andrew G. Kaplan

VP, U.S. Public Affairs, Takeda Pharmaceuticals USA, Inc.

Steve A. Kay, Ph.D., D.Sc.

Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California


Casey Lynch

CEO, Co-founder, and Chairman, Cortexyme

John Maddalon

Principal, Life Science Practice, Deloitte


Nadir Mahmood

Chief Financial and Business Officer of Nkarta Therapeutics

Sean McCarthy

President and Chief Executive Officer, CytomX


Grace Han McMahon

Head of Transactions, Pacific Innovation Hub, Business Development & Licensing, Merck Research Laboratories

Shlomo Melmed, MB, ChB, MACP

Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System

Alan Mendelson

Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP


Dwight Moxie

General Counsel & Corporate Secretary at Revance Therapeutics, Inc

Jamey Millar

Senior Vice President, Managed Markets and Government Affairs, GlaxoSmithKline

Keith Murphy

Founder, CEO, and Chairman, Viscient Biosciences


John Nicols

President and Chief Executive Officer, Codexis

Chris Nolet

Christian W. Nolet


Joshua Ofman

Joshua J. Ofman, M.D., M.S.H.S

Chief of Corporate Strategy and External Affairs, Grail


Christoph Pittius, Ph.D.

Senior Vice President, Research Business Development, City of Hope


Stacey Pugh

Vice President and General Manager, Neurovascular, Medtronic

Ganesh Raman, Ph.D.

Associate Vice Chancellor for Research, California State University


Chetana Rao, Ph.D.

Head, Site Strategy & Operations, Bristol-Myers Squibb, Redwood City

Stephen Richardson

Stephen Richardson

Co-Chief Executive Officer, Alexandria Real Estate (ARE)

Wendye Robbins, MD

President & CEO, Blade Therapeutics

Daria Mochly Rosen

Daria Mochly-Rosen, Ph.D.

The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine

Terry Rosen, Ph.D.

Chief Executive Officer, Arcus Biosciences

Jennifer Ruddock joined Nektar Therapeutics in 2004 and currently serves as Senior Vice President, Strategy and Corporate Affairs. In this role, Ms. Ruddock oversees and leads investor relations, business development, corporate marketing, corporate and employee communications, and public and government affairs functions. Ms. Ruddock's professional experience spans over 25 years in biotechnology, technology and finance. Prior to joining Nektar, Ms. Ruddock held leadership roles in investor relations, financial communications and corporate marketing at a number of public companies, including Catellus Development Corporation (acquired by ProLogis) and Tumbleweed Communications (acquired by Axway). Prior to that, she worked at Montgomery Securities (acquired by Bank of America), a San Francisco-based investment bank which specialized in high technology and healthcare sectors. Ms. Ruddock began her career in medical device sales at Curtin Matheson Scientific, Inc. (acquired by Fisher Scientific). Ms. Ruddock received her undergraduate degree in neuroscience from Colgate University in 1991.

Jennifer Ruddock

Senior Vice President, Strategy & Corporate Affairs, Nektar Therapeutics

George Savage

George Savage M.D.


Paolo Simas

Paulo Simas

Chief Creative Officer, W20 Group


Lesley Stolz, Ph.D.

Managing Director, Lasana Partners


Elizabeth Thompson, Ph.D.

Group Vice President, Development and External Search, Horizon Therapeutics

Robin Toft

Founder and President, Toft Group Executive Search, a ZRG Company


Mohit Trikha, Ph.D.

Vice President, Head of Oncology Early Development, AbbVie


Harold E. Van Wart, Ph.D.



Bridget Walsh

Vice-President, Government Affairs and Public Policy, Boehringer Ingelheim

Jared Watkin

Senior Vice President, Diabetes Care, Abbott

Rick E Winningham

Chairman and CEO, Theravance Biopharma


Alice Zhang

CEO & Founder, Verge Genomics